EDN1 and pulmonary arterial hypertension: Endothelial dysfunction is believed to play an integral role in PAH pathogenesis by decreased production of vasodilators (nitric oxide and prostacyclin) and increased production of vasoconstrictors (thromboxane and endothelin-1) [14].